share_log

Clearmind Medicine | EFFECT: Others

SEC announcement ·  Jan 22 00:00
Summary by Moomoo AI
Clearmind Medicine Inc. has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring the company's submission effective as of January 19, 2024. The submission, identified by Accession Number 0001213900-24-004506 and Submission Type POS AM, pertains to File Number 333-270859. This notice of effectiveness from the SEC is a crucial step for Clearmind Medicine, indicating that the regulatory body has reviewed and accepted the company's filing.
Clearmind Medicine Inc. has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring the company's submission effective as of January 19, 2024. The submission, identified by Accession Number 0001213900-24-004506 and Submission Type POS AM, pertains to File Number 333-270859. This notice of effectiveness from the SEC is a crucial step for Clearmind Medicine, indicating that the regulatory body has reviewed and accepted the company's filing.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more